fig1

Secondary analysis reveals gut microbiota differences in patients with Parkinson's disease and/or cognitive impairment

Figure 1. Study design and clinical indicators. (A) Schematic diagram showing the study design; (B) Differences in clinical scores of PD obtained from various neuropsychological questionnaires. Significant differences were seen in Wilcoxon tests; the corresponding P values are reported. The boxplots show median values with upper and lower quartiles. MMSE: Mini-Mental State Examination; MoCA: Montreal Cognitive Assessment; HAM-A: Hamilton Anxiety Rating Scale; HAMD: Hamilton Depression Scale; PDSS: Parkinson’s Disease Sleep Scale; UPDRS: Unified PD Rating Scale; PD: PD patients with normal cognition (MoCA ≥ 26); PD-CI: PD patients with cognitive impairment (MoCA < 26).

Microbiome Research Reports
ISSN 2771-5965 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/